Ecopipam

N/A

Report date: 2026/05/23 20:00:57
NME

Base Information

Drug NameEcopipam
Drug Alias Name依考匹泮EcopipamumEcopipam HClSch-39166PSYRX-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D5 receptor antagonistsDopamine D1 receptor antagonists
TargetsDopamine D1 receptorDopamine D5 receptor
Therapy Area/IndicationsChildhood-Onset Fluency DisorderGamblingSelf-Injurious Behavior +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesRoyalty Pharma PLCPsyadon Pharmaceuticals IncEmalex Biosciences Inc
Inactive CompaniesUniversity Of California Riverisde School Of MedicinePsyadon Pharma
Active IndicationsStutteringTourette Syndrome
Inactive IndicationsChildhood-Onset Fluency DisorderGamblingSelf-Injurious Behavior +[6] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG